Prognostic Value of Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes: A Retrospective Cohort Study and Meta-Analysis

Jie Jin; Chao Hu; Mengxia Yu; Feifei Chen; Li Ye; Xiufeng Yin; Zhengping Zhuang; Hongyan Tong

doi:10.1371/journal.pone.0100206

Loading metrics

Open Access

Peer-reviewed

Research Article

Prognostic Value of Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes: A Retrospective Cohort Study and Meta-Analysis

Jie Jin,

Affiliations Department of Hematology, the First Affiliated Hospital of Zhejiang University, Hangzhou, People’s Republic of China, Institute of Hematology, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
⨯
Chao Hu,

Affiliations Department of Hematology, the First Affiliated Hospital of Zhejiang University, Hangzhou, People’s Republic of China, Institute of Hematology, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
⨯
Mengxia Yu,

Affiliations Department of Hematology, the First Affiliated Hospital of Zhejiang University, Hangzhou, People’s Republic of China, Institute of Hematology, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
⨯
Feifei Chen,

Affiliations Department of Hematology, the First Affiliated Hospital of Zhejiang University, Hangzhou, People’s Republic of China, Institute of Hematology, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
⨯
Li Ye,

Affiliations Department of Hematology, the First Affiliated Hospital of Zhejiang University, Hangzhou, People’s Republic of China, Institute of Hematology, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
⨯
Xiufeng Yin,

Affiliations Department of Hematology, the First Affiliated Hospital of Zhejiang University, Hangzhou, People’s Republic of China, Institute of Hematology, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
⨯
Zhengping Zhuang,

Affiliation Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America
⨯
Hongyan Tong

* E-mail: zjuhongyantong@163.com

Affiliations Department of Hematology, the First Affiliated Hospital of Zhejiang University, Hangzhou, People’s Republic of China, Institute of Hematology, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China
⨯

Prognostic Value of Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes: A Retrospective Cohort Study and Meta-Analysis

Jie Jin,
Chao Hu,
Mengxia Yu,
Feifei Chen,
Li Ye,
Xiufeng Yin,
Zhengping Zhuang,
Hongyan Tong

Published: June 17, 2014
https://doi.org/10.1371/journal.pone.0100206

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.
Mutation detection
Is the Subject Area "Mutation detection" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Karyotypes
Is the Subject Area "Karyotypes" applicable to this article?

Thanks for your feedback.
Mutation
Is the Subject Area "Mutation" applicable to this article?

Thanks for your feedback.
Myelodysplastic syndromes
Is the Subject Area "Myelodysplastic syndromes" applicable to this article?

Thanks for your feedback.